Verana Health key facts
as of Oct 2026- Operator of a data insights platform intended to accelerate healthcare innovation and optimize drug and device development.
- Verana Health is valued at approximately $628.7M as of Oct 2026 (last reported valuation).
- It has raised $366.5M; the latest was Later Stage VC in Mar 2025.
- Notable investors include GV, Bain Capital Ventures, Novo Holdings, Breyer Capital, Johnson & Johnson JJDC — 22 tracked in total.
- Status: Privately Held (backing).
Verana Health's last reported valuation, Aug 2023. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch Verana Health: the Monday email on marks, rounds and moves
Verana Health funding rounds
No funding rounds for Verana Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Verana Health
22+Verana Health valuation
Verana Health's last reported valuation was $629 million in Aug 2023. No priced round, secondary trade or fund mark has surfaced since.
Verana Health investors
22 investors are on record for Verana Health, including GV, Bain Capital Ventures, Novo Holdings and Breyer Capital. By type, the record holds 9 venture capital firms and 1 private equity firm.
About Verana Health
Operator of a data insights platform intended to accelerate healthcare innovation and optimize drug and device development. The company's platform utilizes regulatory-grade data sets to uncover new market opportunities, enhance trial design and enrollment, gain competitive intelligence to benchmark commercial success, and target marketing efforts among others, enabling life science companies to make informed decisions using data from clinical specialty databases.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2008
- Employees
- 173
- Website
- veranahealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.